AMPH R&D Expense Growth
Amphastar Pharmaceuticals Inc · R&D Expense Growth
AMPH R&D Expense Growth
Latest reported16.14%period ending
AMPH FY R&D Growth (YoY) (0.00% → 16.14%)
Latest values, visible window
High-resolution chart · PNG
AMPH r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 16.1404% | |
| 0.2346% | |
| -1.3775% | |
| 22.7122% | |
| -9.3665% | |
| -2.3586% | |
| 19.6112% | |
| 32.5901% | |
| 5.3788% | |
| 11.1534% | |
| 30.3866% | |
| -13.9071% | |
| 5.9558% | |
| 0.3672% | |
| 0% |